Dr. Reddy’s Laboratories today announced the launch of Sildenafil tablets (20 mg), a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.
This follows the Hyderabad-based pharma major getting approval from the United States Food & Drug Administration for its abbreviated new drug application.
The Revatio brand, a trademark of Prizer Inc., had US sales of approximately $338.67 million for the most recent 12 months ended September 30, 2012, according to IMS Health.
Dr. Reddy’s Sildenafil tablets in 20 mg are available in 90 count bottle sizes.